These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19221586)

  • 1. Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.
    Algar EM; Muscat A; Dagar V; Rickert C; Chow CW; Biegel JA; Ekert PG; Saffery R; Craig J; Johnstone RW; Ashley DM
    PLoS One; 2009; 4(2):e4482. PubMed ID: 19221586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets.
    Gadd S; Sredni ST; Huang CC; Perlman EJ;
    Lab Invest; 2010 May; 90(5):724-38. PubMed ID: 20212451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor receptors as novel therapeutic targets in SNF5-deleted malignant rhabdoid tumors.
    Wöhrle S; Weiss A; Ito M; Kauffmann A; Murakami M; Jagani Z; Thuery A; Bauer-Probst B; Reimann F; Stamm C; Pornon A; Romanet V; Guagnano V; Brümmendorf T; Sellers WR; Hofmann F; Roberts CW; Graus Porta D
    PLoS One; 2013; 8(10):e77652. PubMed ID: 24204904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCB1/INI1 alterations and hepatoblastoma: another extrarenal rhabdoid tumor revealed?
    Russo P; Biegel JA
    Pediatr Blood Cancer; 2009 Mar; 52(3):312-3. PubMed ID: 19072985
    [No Abstract]   [Full Text] [Related]  

  • 5. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor.
    Kerl K; Oyen F; Leuschner I; Schneppenheim R; Nagel I; Siebert R; Groll AH; Hartmann W; Barth PJ; Bartelheim K; Seringer A; Wardelmann E; Frühwald MC
    Pediatr Blood Cancer; 2015 May; 62(5):897-900. PubMed ID: 25663425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA.
    Zhang K; Gao H; Wu X; Wang J; Zhou W; Sun G; Wang J; Wang Y; Mu B; Kim C; Chu P; Ho DM; Ann DK; Wong TT; Yen Y
    Clin Cancer Res; 2014 Mar; 20(5):1179-89. PubMed ID: 24423609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
    Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
    Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
    Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology and Treatment of Rhabdoid Tumor.
    Geller JI; Roth JJ; Biegel JA
    Crit Rev Oncog; 2015; 20(3-4):199-216. PubMed ID: 26349416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.
    Tsikitis M; Zhang Z; Edelman W; Zagzag D; Kalpana GV
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12129-34. PubMed ID: 16099835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
    Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
    J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
    Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
    Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors.
    Hulsebos TJ; Kenter S; Verhagen WI; Baas F; Flucke U; Wesseling P
    Acta Neuropathol; 2014 Sep; 128(3):439-48. PubMed ID: 24740647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
    Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
    Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?
    Rizzo D; Fréneaux P; Brisse H; Louvrier C; Lequin D; Nicolas A; Ranchère D; Verkarre V; Jouvet A; Dufour C; Edan C; Stéphan JL; Orbach D; Sarnacki S; Pierron G; Parfait B; Peuchmaur M; Delattre O; Bourdeaut F
    Am J Surg Pathol; 2012 Jul; 36(7):964-72. PubMed ID: 22614000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells.
    Oruetxebarria I; Venturini F; Kekarainen T; Houweling A; Zuijderduijn LM; Mohd-Sarip A; Vries RG; Hoeben RC; Verrijzer CP
    J Biol Chem; 2004 Jan; 279(5):3807-16. PubMed ID: 14604992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.
    Kim KH; Roberts CW
    Cancer Genet; 2014 Sep; 207(9):365-72. PubMed ID: 24853101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism.
    Gigante L; Paganini I; Frontali M; Ciabattoni S; Sangiuolo FC; Papi L
    Fam Cancer; 2016 Jan; 15(1):123-6. PubMed ID: 26342593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation.
    Han ZY; Richer W; Fréneaux P; Chauvin C; Lucchesi C; Guillemot D; Grison C; Lequin D; Pierron G; Masliah-Planchon J; Nicolas A; Ranchère-Vince D; Varlet P; Puget S; Janoueix-Lerosey I; Ayrault O; Surdez D; Delattre O; Bourdeaut F
    Nat Commun; 2016 Jan; 7():10421. PubMed ID: 26818002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.